» Articles » PMID: 11777936

Fyn Tyrosine Kinase is a Downstream Mediator of Rho/PRK2 Function in Keratinocyte Cell-cell Adhesion

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2002 Jan 5
PMID 11777936
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

The Rho GTPase and Fyn tyrosine kinase have been implicated previously in positive control of keratinocyte cell-cell adhesion. Here, we show that Rho and Fyn operate along the same signaling pathway. Endogenous Rho activity increases in differentiating keratinocytes and is required for both Fyn kinase activation and increased tyrosine phosphorylation of beta- and gamma-catenin, which is associated with the establishment of keratinocyte cell-cell adhesion. Conversely, expression of constitutive active Rho is sufficient to promote cell-cell adhesion through a tyrosine kinase- and Fyn-dependent mechanism, trigger Fyn kinase activation, and induce tyrosine phosphorylation of beta- and gamma-catenin and p120ctn. The positive effects of activated Rho on cell-cell adhesion are not induced by an activated Rho mutant with defective binding to the serine/threonine PRK2/PKN kinases. Endogenous PRK2 kinase activity increases with keratinocyte differentiation, and, like activated Rho, increased PRK2 activity promotes keratinocyte cell-cell adhesion and induces tyrosine phosphorylation of beta- and gamma-catenin and Fyn kinase activation. Thus, these findings reveal a novel role of Fyn as a downstream mediator of Rho in control of keratinocyte cell-cell adhesion and implicate the PRK2 kinase, a direct Rho effector, as a link between Rho and Fyn activation.

Citing Articles

Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes.

Stevenson M, Algarzae N, Moussa C Front Dement. 2024; 3:1458038.

PMID: 39221072 PMC: 11361951. DOI: 10.3389/frdem.2024.1458038.


FYN: emerging biological roles and potential therapeutic targets in cancer.

Peng S, Fu Y J Transl Med. 2023; 21(1):84.

PMID: 36740671 PMC: 9901160. DOI: 10.1186/s12967-023-03930-0.


Src Family Kinases: A Potential Therapeutic Target for Acute Kidney Injury.

Li N, Lin G, Zhang H, Sun J, Gui M, Liu Y Biomolecules. 2022; 12(7).

PMID: 35883540 PMC: 9312434. DOI: 10.3390/biom12070984.


ROCK 'n TOR: An Outlook on Keratinocyte Stem Cell Expansion in Regenerative Medicine via Protein Kinase Inhibition.

Centonze G, Centonze S, Ponzone L, Calautti E Cells. 2022; 11(7).

PMID: 35406693 PMC: 8997668. DOI: 10.3390/cells11071130.


Comparative Transcriptome Analysis of Spleen Reveals Potential Regulation of Genes and Immune Pathways Following Administration of Aeromonas salmonicida subsp. masoucida Vaccine in Atlantic Salmon (Salmo salar).

Fu Q, Li Y, Zhang H, Cao M, Zhang L, Gao C Mar Biotechnol (NY). 2022; 24(1):97-115.

PMID: 35084599 PMC: 8792528. DOI: 10.1007/s10126-021-10089-6.


References
1.
Van Aelst L, DSouza-Schorey C . Rho GTPases and signaling networks. Genes Dev. 1997; 11(18):2295-322. DOI: 10.1101/gad.11.18.2295. View

2.
BRAGA V, Machesky L, Hall A, Hotchin N . The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J Cell Biol. 1997; 137(6):1421-31. PMC: 2132529. DOI: 10.1083/jcb.137.6.1421. View

3.
Hall A . Rho GTPases and the actin cytoskeleton. Science. 1998; 279(5350):509-14. DOI: 10.1126/science.279.5350.509. View

4.
Sahai E, Alberts A, Treisman R . RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J. 1998; 17(5):1350-61. PMC: 1170483. DOI: 10.1093/emboj/17.5.1350. View

5.
He T, Zhou S, DA COSTA L, Yu J, Kinzler K, Vogelstein B . A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A. 1998; 95(5):2509-14. PMC: 19394. DOI: 10.1073/pnas.95.5.2509. View